News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Brazil’s Eurofarma Laboratórios SA is to manufacture Pfizer and BioNTech's COVID-19 vaccine, Comirnaty, for distribution within Latin America.
Cold chain logistics provider, Cryoport, has established a multi-year strategic partnership with Japan’s Mitsubishi Logistics Corporation (MLC).
A new partnership promises improved biomanufacturing processes for gene therapies; the goal is to support the sector in scaling up through more efficient, cost-effective processes.
The European Medicines Agency’s human medicines committee (EMA CHMP) has this week approved additional manufacturing capacity for Pfizer/BioNTech and Moderna COVID-19 vaccines.
The International Vaccine Institute (IVI) and Bharat Biotech have started a Phase 2/3 clinical trial for a chikungunya vaccine candidate in Costa Rica.